← Eichor
Condition: Temporal Lobe Epilepsy Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Temporal Lobe Epilepsy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

SeizEAR Safety Study
NA · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT07088835AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
Phase 1/Phase 2 · 18 location(s) · UniQure Biopharma B.V. · NCT06063850Spatial Scene Recognition Memory in Epilepsy Surgery
NA · 2 location(s) · University of California, Davis · NCT07580183MRgLITT for mTLE: A PROBE Trial
NA · 1 location(s) · Beijing Tiantan Hospital · NCT06720922A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Dr
Phase 1/Phase 2 · 3 location(s) · NaviFUS Corporation · NCT06388707A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)
Phase 1/Phase 2 · 17 location(s) · Neurona Therapeutics · NCT06422923Investigating Epilepsy: Screening and Evaluation
Phase N/A · 1 location(s) · National Institute of Neurological Disorders and Stroke (NIN · NCT03478852Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell T
Phase 3 · 35 location(s) · Neurona Therapeutics · NCT05135091Changes in Attentional Control After a Focal Seizure.
Phase N/A · 1 location(s) · University Hospital, Lille · NCT06466681Pharmacological Modulation of Brain Oscillations in Memory Processing
EARLY_Phase 1 · 1 location(s) · University of Texas Southwestern Medical Center · NCT05594017Enhanced MRI Imaging in Healthy Participants and Participants With Epilepsy
Phase 2 · 1 location(s) · University of Alberta · NCT06483061Pathophysiology, Psycho-emotional and Cognitive Functioning Associated With Tinnitus
NA · 2 location(s) · Assistance Publique - Hôpitaux de Paris · NCT04717388PRIME: PReservIng Memory in Epilepsy
NA · 2 location(s) · Nitin Tandon · NCT05608408Evaluation of the NaviFUS System in Drug Resistant Epilepsy
NA · 1 location(s) · Genovate-NaviFUS (Australia) Pty Ltd. · NCT05947656Capturing Autobiographical Memory Formation in Real World Spaces Using Multimodal Recordings
NA · 1 location(s) · University of Utah · NCT06883981Intensive Preoperative Speech Rehabilitation in Drug-Resistant Temporal Epilepsy
NA · 12 location(s) · Assistance Publique Hopitaux De Marseille · NCT05609084Surgery as a Treatment for Medically Intractable Epilepsy
Phase N/A · 1 location(s) · National Institute of Neurological Disorders and Stroke (NIN · NCT01273129Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and
Phase N/A · 1 location(s) · Assistance Publique Hopitaux De Marseille · NCT07202494Localizing Epileptic Networks Using MRI and iEEG
EARLY_Phase 1 · 1 location(s) · University of Pennsylvania · NCT04649008Exploratory Study of UX-GIP001 Cell Therapy in Adult Patients With Drug-Resistant Unilateral Mesial Temporal Lobe Epilep
EARLY_Phase 1 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07244328Pre-operative Mapping of the Anterior Temporal Lobe Using Functional MRI Innovative Techniques in in Drug-resistant Epil
NA · 1 location(s) · Central Hospital, Nancy, France · NCT05339438A Pilot Study to Evaluate the Efficacy and Safety of NaviFUS™ System Neuromodulating Treatment for Patients With Drug Re
NA · 1 location(s) · NaviFUS Corporation · NCT06492720
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.